EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance

By Dua Rajiv  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 685-697

Springer Publishing Company

Access to resources Recommend Favorite

Investigating the Combination of Trastuzumab and HER2/neu Peptide Vaccines for the Treatment of Breast Cancer

By Mittendorf Elizabeth   Storrer Catherine   Shriver Craig   Ponniah Sathibalan   Peoples George  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1085-1098

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

Prostate cancer cell lines lack amplification: Overexpression of HER2

By Ullén Anders   Lennartsson Lena   Harmenberg Ulrika   Lennernäs Bo   Majumder Khairul   Holmberg Anders   Nilsson Sten   Elmberger Göran  

Acta Oncologica, Vol. 44, Iss. 5, 2005-07 ,pp. : 490-495

Informa Healthcare

Access to resources Recommend Favorite

HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer

By Konecny G.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 53-63

Springer Publishing Company

Access to resources Recommend Favorite